Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001104659-15-017148
Filing Date
2015-03-05
Accepted
2015-03-05 16:25:59
Documents
3
Group Members
CARE CAPITAL II LLCCARE CAPITAL INVESTMENTS II LPCARE CAPITAL INVESTMENTS III LPCARE CAPITAL OFFSHORE INVESTMENTS II LPCARE CAPITAL OFFSHORE INVESTMENTS III LP

Document Format Files

Seq Description Document Type Size
1 SC 13D a15-6078_1sc13d.htm SC 13D 182372
2 EX-1 a15-6078_1ex1.htm EX-1 26097
3 EX-2 a15-6078_1ex2.htm EX-2 32296
  Complete submission text file 0001104659-15-017148.txt   242492
Mailing Address 131 HARTWELL AVE 1ST FLOOR, SUITE 105 LEXINGTON MA 02421
Business Address 131 HARTWELL AVE 1ST FLOOR, SUITE 105 LEXINGTON MA 02421 781-676-2100
INOTEK PHARMACEUTICALS CORP (Subject) CIK: 0001281895 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88750 | Film No.: 15677666
SIC: 2834 Pharmaceutical Preparations

Mailing Address 47 HULFISH STREET PRINCETON NJ 08542
Business Address 47 HULFISH STREET PRINCETON NJ 08542 609-683-8300
Care Capital III LLC (Filed by) CIK: 0001599356 (see all company filings)

EIN.: 861148590 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D